The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 05, 2021

Filed:

May. 12, 2017
Applicant:

The Scripps Research Institute, La Jolla, CA (US);

Inventors:

Zaverio Ruggeri, La Jolla, CA (US);

Wolfram Ruf, San Diego, CA (US);

Yuichi Kamikubo, San Diego, CA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/745 (2006.01); G01N 33/86 (2006.01); C12N 9/64 (2006.01); A61P 7/02 (2006.01);
U.S. Cl.
CPC ...
C07K 14/745 (2013.01); A61P 7/02 (2018.01); C12N 9/644 (2013.01); C12Y 304/21022 (2013.01); G01N 33/86 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract

In various embodiments, disclosed herein are assays for measuring thrombin generated (TG) in a blood sample, comprising: incubating the blood sample with TF, FIXa, and CaCl2; and measuring TG in the blood sample. Also disclosed herein are assays for determining a bleeding risk in a subject, comprising obtaining a blood sample from the subject; adding to the blood sample TF and/or FIXa; determining the amount of coagulation factor VIII (FVIII:C) in the blood sample; and determining (a) a mild bleeding risk in the subject if the amount of FVIII:C in the sample is >5 IU/dL, (b) a moderate bleeding risk in the subject if the amount of FVIII:C in the sample is 1-5 IU/dL, and (c) a severe bleeding risk in the subject if the amount of FVIII:C in the subject is <1 IU/dL.


Find Patent Forward Citations

Loading…